News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Myeloma Paper of the Day, February 2nd, suggested by Robert Orlowski
Robert Orlowski/mdanderson.org
Feb 2, 2025, 14:57

Myeloma Paper of the Day, February 2nd, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Nationwide, population-based study in Netherlands on factors and considerations in no-treatment decisions in patients with hematological malignancies finds primary reason related to physical condition, 2nd reason was patient/family choice.”

Factors and Considerations in No-Treatment Decisions in Patients With Key Hematological Malignancies: A Nationwide, Population-Based Study in the Netherlands

Authors: Myrte Zijlstra et al.

Myeloma Paper of the Day, February 2nd, suggested by Robert Orlowski

 

More posts featuring Robert Orlowski.

Avinash G. Dinmohamed cancer hematological malignancies MD Anderson Cancer Center Myeloma Paper of the Day Myrte Zijlstra OncoDaily Oncology Robert Orlowski Rolf A. H. Snijders
Special Coverage
Blog
Apr 14, 2025, 04:50
Joshua Reuss: Excellent updates on thymoma/thymic carcinoma from Chul Kim at TexasLung25
Blog
Apr 14, 2025, 04:39
Michael Duruisseaux: Phase 3 DeLLphi-304 - Tarlatamab Meets OS Endpoint in SCLC
Blog
Apr 14, 2025, 03:45
Alfredo Addeo: The Phase 3 DeLLphi-304 trial met its primary endpoint
Blog
Apr 14, 2025, 01:50
Giannis Mountzios: Tarlatamab Improves Overall Survival in Advanced SCLC
Blog
Apr 14, 2025, 01:36
Sumanta K. Pal: Best Talk This Year - City of Hope GU Retreat
Blog
Apr 14, 2025, 01:08
The Faces of Cancer Care: Strengthening the Workforce, Saving Lives - UICC
Blog
Apr 13, 2025, 19:03
Tigran Byuzandyan: Delegation from the National Oncology Center of Armenia Explores Collaboration with Heidelberg University Hospital
Blog
Apr 13, 2025, 18:24
Akhil Santhosh: First-Line Adagrasib and Pembrolizumab for Metastatic NSCLC
Blog
Apr 13, 2025, 18:15
12th Annual Cholangiocarcinoma Foundation Conference Comes to a Close
Blog
Apr 13, 2025, 17:50
Noemi Reguart: First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy in SCLC
Blog
Apr 13, 2025, 17:15
Applications are open for the M2ICOS project - European School of Oncology
Stories
Apr 13, 2025, 17:11
From Resident to Survivor: Dr. Jessica Firdman Moore’s cancer journey at Sylvester Comprehensive Cancer Center